254 related articles for article (PubMed ID: 30918495)
1. Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy.
Camacho J; Moliné T; Bonaterra-Pastra A; Ramón Y Cajal S; Martínez-Sáez E; Hernández-Guillamon M
Front Neurol; 2019; 10():187. PubMed ID: 30918495
[TBL] [Abstract][Full Text] [Related]
2. ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy.
Montañola A; de Retana SF; López-Rueda A; Merino-Zamorano C; Penalba A; Fernández-Álvarez P; Rodríguez-Luna D; Malagelada A; Pujadas F; Montaner J; Hernández-Guillamon M
Neuromolecular Med; 2016 Mar; 18(1):99-108. PubMed ID: 26661731
[TBL] [Abstract][Full Text] [Related]
3. Association of candidate genetic variants and circulating levels of ApoE/ApoJ with common neuroimaging features of cerebral amyloid angiopathy.
Bonaterra-Pastra A; Benítez S; Pancorbo O; Rodríguez-Luna D; Vert C; Rovira A; Freijo MM; Tur S; Martínez-Zabaleta M; Cardona Portela P; Vera R; Lebrato-Hernández L; Arenillas JF; Pérez-Sánchez S; Domínguez-Mayoral A; Fàbregas JM; Mauri G; Montaner J; Sánchez-Quesada JL; Hernández-Guillamon M
Front Aging Neurosci; 2023; 15():1134399. PubMed ID: 37113571
[TBL] [Abstract][Full Text] [Related]
4. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.
Hondius DC; Eigenhuis KN; Morrema THJ; van der Schors RC; van Nierop P; Bugiani M; Li KW; Hoozemans JJM; Smit AB; Rozemuller AJM
Acta Neuropathol Commun; 2018 Jun; 6(1):46. PubMed ID: 29860944
[TBL] [Abstract][Full Text] [Related]
5. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
[TBL] [Abstract][Full Text] [Related]
6. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
[TBL] [Abstract][Full Text] [Related]
7. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
Chalmers K; Wilcock GK; Love S
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320
[TBL] [Abstract][Full Text] [Related]
8. Peripheral administration of human recombinant ApoJ/clusterin modulates brain beta-amyloid levels in APP23 mice.
de Retana SF; Marazuela P; Solé M; Colell G; Bonaterra A; Sánchez-Quesada JL; Montaner J; Maspoch D; Cano-Sarabia M; Hernández-Guillamon M
Alzheimers Res Ther; 2019 May; 11(1):42. PubMed ID: 31077261
[TBL] [Abstract][Full Text] [Related]
9. Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype.
Tanskanen M; Lindsberg PJ; Tienari PJ; Polvikoski T; Sulkava R; Verkkoniemi A; Rastas S; Paetau A; Kiuru-Enari S
Neuropathol Appl Neurobiol; 2005 Dec; 31(6):589-99. PubMed ID: 16281907
[TBL] [Abstract][Full Text] [Related]
10. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
[TBL] [Abstract][Full Text] [Related]
11. Cerebral amyloid angiopathy and dementia.
Tian J; Shi J; Mann DM
Panminerva Med; 2004 Dec; 46(4):253-64. PubMed ID: 15876981
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of cerebral amyloid angiopathy caused by chaotic glymphatics-Mini-review.
Lui F; Alcaide J; Knowlton S; Ysit M; Zhong N
Front Neurosci; 2023; 17():1180237. PubMed ID: 37113157
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Plasma Lipoprotein Composition and Function in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
Bonaterra-Pastra A; Fernández-de-Retana S; Rivas-Urbina A; Puig N; Benítez S; Pancorbo O; Rodríguez-Luna D; Pujadas F; Freijo MDM; Tur S; Martínez-Zabaleta M; Cardona Portela P; Vera R; Lebrato-Hernández L; Arenillas JF; Pérez-Sánchez S; Montaner J; Sánchez-Quesada JL; Hernández-Guillamon M
Biomedicines; 2021 Jan; 9(1):. PubMed ID: 33445800
[TBL] [Abstract][Full Text] [Related]
14. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in amyloid precursor protein transgenic mice.
Fryer JD; Taylor JW; DeMattos RB; Bales KR; Paul SM; Parsadanian M; Holtzman DM
J Neurosci; 2003 Aug; 23(21):7889-96. PubMed ID: 12944519
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation at CR1 increases risk of cerebral amyloid angiopathy.
Biffi A; Shulman JM; Jagiella JM; Cortellini L; Ayres AM; Schwab K; Brown DL; Silliman SL; Selim M; Worrall BB; Meschia JF; Slowik A; De Jager PL; Greenberg SM; Schneider JA; Bennett DA; Rosand J
Neurology; 2012 Jan; 78(5):334-41. PubMed ID: 22262751
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E and clusterin inhibit the early phase of amyloid-β aggregation in an in vitro model of cerebral amyloid angiopathy.
Endo Y; Hasegawa K; Nomura R; Arishima H; Kikuta KI; Yamashita T; Inoue Y; Ueda M; Ando Y; Wilson MR; Hamano T; Nakamoto Y; Naiki H
Acta Neuropathol Commun; 2019 Jan; 7(1):12. PubMed ID: 30691533
[TBL] [Abstract][Full Text] [Related]
19. Cerebrovascular pathology in cerebral amyloid angiopathy presenting as intracerebral haemorrhage.
Poyuran R; Mahadevan A; Arimappamagan A; Nandeesh BN; Nagappa M; Saini J; Narasinga Rao KVL; Chickabasaviah YT
Virchows Arch; 2019 Feb; 474(2):235-245. PubMed ID: 30617647
[TBL] [Abstract][Full Text] [Related]
20. Regulatory effects of simvastatin and apoJ on APP processing and amyloid-β clearance in blood-brain barrier endothelial cells.
Zandl-Lang M; Fanaee-Danesh E; Sun Y; Albrecher NM; Gali CC; Čančar I; Kober A; Tam-Amersdorfer C; Stracke A; Storck SM; Saeed A; Stefulj J; Pietrzik CU; Wilson MR; Björkhem I; Panzenboeck U
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jan; 1863(1):40-60. PubMed ID: 28941799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
